PART I . Overview We are a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company has a portfolio of proprietary products derived from ethically sourced birth tissue, including mesenchymal stem cells, stem cell and amniotic fluid derived exosomes and Whartons Jelly matrix. The Companys principal product is Zofin, a product derived from amniotic fluid a...
expected 2026-10-20
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-01-29 | 2025-10-31 | 0001829126-26-000763 | EDGAR | 65K words |
| 2025-01-29 | 2024-10-31 | 0001829126-25-000536 | EDGAR | 58K words |
| 2024-01-29 | 2023-10-31 | 0001829126-24-000541 | EDGAR | 71K words |
| 2023-02-14 | 2022-10-31 | 0001829126-23-001524 | EDGAR | — |
| 2022-02-14 | 2021-10-31 | 0001829126-22-003605 | EDGAR | — |
| 2021-02-08 | 2020-10-31 | 0001829126-21-000414 | EDGAR | — |
| 2020-10-16 | 2019-10-31 | 0001683168-20-003466 | EDGAR | — |
| 2020-03-06 | 2018-10-31 | 0001683168-20-000712 | EDGAR | — |
| 2018-11-01 | 2017-10-31 | 0001683168-18-003206 | EDGAR | — |
| 2017-07-07 | 2016-10-31 | 0001493152-17-007610 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-17 | 2026-01-31 | 0001829126-26-002396 | EDGAR | 17K words |
| 2025-09-15 | 2025-07-31 | 0001829126-25-007398 | EDGAR | 21K words |
| 2025-06-16 | 2025-04-30 | 0001829126-25-004512 | EDGAR | 19K words |
| 2025-03-17 | 2025-01-31 | 0001829126-25-001828 | EDGAR | 15K words |
| 2024-09-16 | 2024-07-31 | 0001829126-24-006296 | EDGAR | 19K words |
| 2024-06-14 | 2024-04-30 | 0001829126-24-004217 | EDGAR | 17K words |
| 2024-03-18 | 2024-01-31 | 0001829126-24-001677 | EDGAR | 14K words |
| 2023-09-14 | 2023-07-31 | 0001829126-23-006098 | EDGAR | 24K words |
| 2023-06-16 | 2023-04-30 | 0001829126-23-004245 | EDGAR | 23K words |
| 2023-03-17 | 2023-01-31 | 0001829126-23-002113 | EDGAR | — |
| 2022-09-14 | 2022-07-31 | 0001829126-22-016867 | EDGAR | — |
| 2022-06-14 | 2022-04-30 | 0001829126-22-013532 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-15 | 0001829126-26-010100 | EDGAR | 1K words |
| 2026-09-15 | 0001829126-26-010114 | EDGAR | 1K words |
| 2026-09-01 | 0001829126-26-009583 | EDGAR | 1K words |
| 2026-08-04 | 0001829126-26-008299 | EDGAR | 1K words |
| 2026-07-21 | 0001829126-26-007689 | EDGAR | 1K words |
| 2026-03-31 | 0001829126-26-002881 | EDGAR | 1K words |
| 2026-03-27 | 0001829126-26-002789 | EDGAR | 0K words |
| 2026-01-28 | 0001829126-26-000610 | EDGAR | 5K words |
| 2026-01-21 | 0001829126-26-000431 | EDGAR | 1K words |
| 2026-01-07 | 0001829126-26-000073 | EDGAR | 1K words |
208 total filings indexed. 176 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001557376 |
| Ticker | ZEOX |
| Exchange | OTC |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | NV |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ZEOX (~200 tokens, structured JSON with cryptographic provenance)